UnitedHealth Group Incorporated
UNH
Below: live stock price for UnitedHealth Group Incorporated (UNH), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.
UnitedHealth Group Incorporated (UNH) is a Healthcare company based in United States. Operating in Healthcare Plans, it employs about 390,000 people. Over the past year UNH traded between 255.97 and 461.62 USD. Trailing P/E sits near 23.23 on a market cap of about 365.29B USD. It currently yields 2.28% in dividends.
- Prev close
- $410.91
- Volume (24h)
- $1.75B
- Market cap
- $365.29B
- Currency
- USD
Score
49/ 100 · Mixed
- Value62
- Quality37
- Momentum48
- Growth64
- Risk77
- Dividend46
- Liquidity6
Composite of public market data. Informational only — not investment advice.
Trend projection
Where the recent trend points if it continues.
- +5 bars
- 407.1514 +0.04%
- +20 bars
- 407.4019 +0.11%
- +60 bars
- 407.4988 +0.13%
- +120 bars
- 407.5024 +0.13%
Linear-regression continuation — not a prediction, not investment advice. ±1σ ≈ 68% range · ±2σ ≈ 95% range: 1σ ≈ ±1.46% per bar.
Interpretation
Composite signals look mixed. Strength: risk profile with weakness: balance-sheet liquidity. Price sits near the upper third of the recent range, trend is roughly flat.
Descriptive observation — not investment advice.
Score breakdown
Raw values behind each pillar so you can see what the composite is reading.
- Value62/100
Value looks solid — driven by P/E (23.23).
P/E:23.23P/B:3.53PEG:1.04 - Quality37/100
Quality looks weak — driven by Gross margin (20.05%).
ROE:15.77%ROA:5.24%Profit margin:3.53%Gross margin:20.05% - Momentum48/100
Momentum looks mixed — driven by 52w change (21.92%).
52w change:21.92% - Growth64/100
Growth looks solid — driven by Earnings growth (75.90%).
Revenue growth:-0.40%Earnings growth:75.90% - Risk77/100
Risk looks strong — driven by Debt / equity (70.43).
Beta:0.62Debt / equity:70.43Short interest:1.74% - Dividend46/100
Dividend looks mixed — driven by Payout ratio (57.56%).
Dividend yield:2.28%Payout ratio:57.56% - Liquidity6/100
Liquidity looks fragile — driven by Current ratio (0.74).
Current ratio:0.74Quick ratio:0.42
Derived from public market data — informational, not investment advice.
Price report
How this asset has actually moved over the last 251 days.
Where the price sits between the window low and high.
- Volatility (annualised)
- 35.8%
- Max drawdown
- -27.3%
- Below period high
- -11.8%
- Best day
- +9.37%
- Worst day
- -19.61%
- Up days
- 47%
- Current streak
- 1 down
- Typical day swing
- 2.5%
- Volume vs average
- -25%
Spread of returns. Higher means larger swings in both directions.
Worst peak-to-trough fall inside the window.
Current price against the highest point in the window.
Share of days that closed above the one before.
Average high-to-low spread within a single day.
Last 10 days against the whole window.
Descriptive statistics over past prices — not a forecast and not investment advice.
Reference levels
Fibonacci retracements and extensions across the recent range.
Reference only — not investment advice.
These coordinates describe past-trade clustering, not where to buy or sell. Do your own research before any trade.
Levels derived from: 426.55 high → 362.6 low · 60 bars
- ResistanceFib +161.8% extensionnot reached530.0211 USD+30.24% from current
- ResistanceFib +100% extensionnot reached490.5 USD+20.52% from current
- ResistanceFib +61.8% extensionnot reached466.0711 USD+14.52% from current
- ResistanceFib +27.2% extensionnot reached443.9444 USD+9.09% from current
- ResistanceFib 23.6% retracementNearesttested 9×411.4578 USD+1.10% from current
- Current406.97 USD
- SupportFib 38.2% retracementtested 13×402.1211 USD-1.19% from current
- SupportFib 50% midpointtested 12×394.575 USD-3.05% from current
- SupportFib 61.8% retracementtested 8×387.0289 USD-4.90% from current
- SupportFib 78.6% retracementtested 17×376.2853 USD-7.54% from current
- SupportFib −27.2% extensionnot reached345.2056 USD-15.18% from current
- SupportFib −61.8% extensionnot reached323.0789 USD-20.61% from current
- SupportFib −100% extensionnot reached298.65 USD-26.62% from current
How to read this
We take the highest and lowest price of the last 60 bars and cut the gap between them at the classic Fibonacci ratios (23.6%, 38.2%, 50%, 61.8%, 78.6%), plus extensions beyond both ends.
“Tested N×” counts how many of those 60 bars actually traded through the level. A level price has crossed many times is one the market has repeatedly agreed on; a level at 0 is pure geometry the price has never reached.
This is a map of where trading has already happened — not a forecast and not a signal. Price moves through these levels all the time.
Financials
- 52w high
- $461.62
- 52w low
- $255.97
- 52w change
- 21.92%
- Day high
- $416.11
- Day low
- $405.91
- P/E (TTM)
- 23.23
- Forward P/E
- 17.48
- PEG
- 1.04
- Price / Book
- 3.53
- Beta (5Y)
- 0.62
- Enterprise value
- 414.28B
- EV / Revenue
- 0.92
- EV / EBITDA
- 14.33
- EPS (TTM)
- $17.52
- Forward EPS
- $23.29
- Dividend yield
- 2.28%
- Dividend rate
- $9.28
- Payout ratio
- 57.56%
- Revenue (TTM)
- 450.06B
- EBITDA
- 28.9B
- Free cash flow
- 26.5B
- Total cash
- 28.55B
- Total debt
- 74.33B
- Debt / Equity
- 70.43
- Current ratio
- 0.74
- Quick ratio
- 0.42
- Profit margin
- 3.53%
- Gross margin
- 20.05%
- Return on assets
- 5.24%
- Return on equity
- 15.77%
- Shares outstanding
- 897.59M
- Float
- 899.41M
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; Medicaid plans, including Temporary Assistance to Needy Families; Children's Health Insurance Programs; Dual SNPs; Long-Term Services and Supports; Aged, Blind and Disabled; and other federal, state, and community health care programs. and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.
Analyst & Risk
Analysts' consensus via Yahoo Finance — not investment advice.
- Beta (vs S&P 500)
- 0.62
- less volatile
- 52-week change
- 21.92%
- Short % of float
- 1.74%
- Short ratio (days)
- 2.43
- Debt / Equity
- 70.43
- very high leverage
- Current ratio
- 0.74
- Quick ratio
- 0.42
- ROE
- 15.77%
- ROA
- 5.24%
- PEG ratio
- 1.04
- EV / Revenue
- 0.92
- EV / EBITDA
- 14.33
- Revenue growth
- -0.40%
- Earnings growth
- 75.90%
- EBITDA
- 28.9B
- Free cash flow
- 26.5B
- Total cash
- 28.55B
- Total debt
- 74.33B
- Insider holdings
- 0.25%
- Institutional
- 89.65%
Recent rating changes
- 2026-10-27Wells FargoOverweight → Overweightmain
- 2026-10-27Morgan StanleyOverweight → Overweightmain
- 2026-10-22MizuhoOutperform → Outperformmain
- 2026-10-20RBC CapitalOutperform → Outperformmain
- 2026-10-16BernsteinOutperform → Outperformmain
- 2026-10-16JP MorganOverweight → Overweightmain
- 2026-10-15TD CowenHold → Holdreit
- 2026-10-14Piper SandlerOverweight → Overweightmain
Financial documents
- Corporate Changes & Voting Matters8-K2026-10-13
- Corporate Changes & Voting Matters8-K2026-09-08
- Periodic Financial Reports10-Q2026-08-10
- Corporate Changes & Voting Matters8-K2026-07-16
- Annual report of employee stock purchase11-K2026-06-11
- Corporate Changes & Voting Matters8-K2026-06-05
- Proxy StatementsDEFA14A2026-05-15
- Corporate Changes & Voting Matters8-K2026-05-11
- Periodic Financial Reports10-Q2026-05-05
- Corporate Changes & Voting Matters8-K2026-04-21
- Corporate Changes & Voting Matters8-K2026-03-09
- Periodic Financial Reports10-K2026-03-02
Recent news
- Why UnitedHealth Stock Can Still Gain After This Year’s 24% RallyBarrons.com14 hr. ago
- What UnitedHealth Group Bulls Got RightSimply Wall St.yesterday
- BridgeBio's Heart Disorder Drug Attruby Faces Unanticipated Near-Term Tailwinds, UBS SaysMT Newswiresyesterday
- 1 safe-and-steady stock to research further and 2 we find riskyStockStoryyesterday
- $250,000 in Merck, Pfizer, UnitedHealth and AbbVie Could Pay $8,000 a Year in Dividends24/7 Wall St.yesterday
- BrightSpring Soars 12% on Q3 Beat and Raised 2026 Guidance as Adjusted EBITDA Jumps 42%TIKRyesterday
- As the Nasdaq wobbles on capex, this Buffett strategy went 15-for-15Investing.comyesterday
- THC Q3 Earnings Beat on Hospital Strength, 2026 EPS View RaisedZacks2 days ago
Related
Other assets in this category.
Learn the terms
Live discussion
Sign in to join the discussion.
- No comments yet. Be the first.